N | 100 |
---|---|
Mean Age ± SD (range) | 67.5 ±8.3 (51 – 88) |
Race | % |
White | 37 |
Black | 50 |
Asian | 4 |
Other, Unknown, Hispanic | 9 |
Median PSA (range) | 7.6 (1–40.9) |
T stage | % |
T1c | 90 |
T2a | 7 |
T3a | 2 |
T3b | 1 |
Gleason Score | % |
6 | 32 |
7 | 54 |
8 | 7 |
9 | 6 |
Risk group | % |
Low risk | 32 |
Intermediate risk | 49 |
High risk | 19 |
Co-morbid conditions | % |
GU PMH | 34 |
HTN | 72 |
DM | 27 |
Hyperlipidemia | 47 |
Hemorrhoids | 11 |
ADT | 40 |
Calypso® | 38 |